Your session is about to expire
← Back to Search
Chest Wall Mechanics Study for Heart Disease
N/A
Waitlist Available
Led By Luciana Rodriguez Guerineau, MD
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Undergone surgery using CPB for congenital heart disease
Aged <28 days of life at the time of cardiac surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 30 days post-operation or discharge (whichever comes first)
Awards & highlights
Study Summary
This trialstudies how babies' chest walls move during delayed sternal closure surgery after heart surgery or treatment.
Who is the study for?
This trial is for newborns under 28 days old who have had surgery for congenital heart disease and need their chest kept open in the critical care unit. They must weigh over 2 kg, be at least full-term babies, and not require certain advanced respiratory or circulatory support.Check my eligibility
What is being tested?
The study tests how different breathing machine settings affect the chest wall during delayed sternal closure after heart surgery. It uses a special catheter to measure pressure inside the esophagus of these infants.See study design
What are the potential side effects?
Potential side effects may include discomfort from the catheter placement, risk of infection at the insertion site, and possible interference with normal breathing patterns due to measurement procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had heart surgery with a heart-lung machine for a birth defect.
Select...
My baby was younger than 28 days old at the time of their heart surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ prior to and immediately after sternal chest wall closure procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~prior to and immediately after sternal chest wall closure procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percentage of patients with successful insertion and measurement of esophageal pressures
Secondary outcome measures
Changes in transmural pressures
Chest wall and lung compliance
Duration of inotropic support
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Univentricular physiologyExperimental Treatment1 Intervention
Neonates with univentricular physiology
Group II: Biventricular physiologyExperimental Treatment1 Intervention
Neonates with biventricular physiology
Find a Location
Who is running the clinical trial?
The Hospital for Sick ChildrenLead Sponsor
686 Previous Clinical Trials
6,944,753 Total Patients Enrolled
Children's Hospital Los AngelesOTHER
232 Previous Clinical Trials
5,076,728 Total Patients Enrolled
Luciana Rodriguez Guerineau, MDPrincipal InvestigatorThe Hospital for Sick Children
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a heart rhythm problem that affects my blood flow.Having a drug screening test in a specialized care unit.I had heart surgery with a heart-lung machine for a birth defect.My baby was born before 37 weeks or weighed less than 2 kg at surgery time.You have a severe blood clotting problem or a condition that makes it unsafe to insert a tube through your nose into your stomach.My baby was younger than 28 days old at the time of their heart surgery.There is too much air leaking around the breathing tube.I require a machine to help with my heart and lungs function.I have a lung condition I was born with.
Research Study Groups:
This trial has the following groups:- Group 1: Univentricular physiology
- Group 2: Biventricular physiology
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies for prospective participants in this clinical trial?
"Reports on clinicaltrials.gov confirm that this trial is presently looking for participants, with initial posting occurring on August 1st 2022 and the most recent update made on October 26th 2022."
Answered by AI
How many individuals are involved in the current research endeavor?
"Affirmative. Clinicaltrials.gov contains evidence that the trial is actively searching for volunteers to take part; this endeavour was initially posted on August 1st of 2022 and has been recently revised on October 26th, 2022. The project requires 40 participants from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger